glp 1 and inflammation Anti-inflammatory properties of GLP-1 receptor agonists other ancillary benefits from a pharmacological perspective Central glucagon-like peptide 1 receptor
Description
Jastreboff AM, Kaplan LM, Fras JP, Wu Q, Du Y, Gurbuz S, et al
Thyroid 35 , 6978 (2025)
The brand describes them as taken daily rather than weekly
This is a large, carefully designed observational study not a randomised trial so it points to a promising signal rather than a proven benefit
